Stay updated with breaking news from Bart Staels. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Genfit (NASDAQ:GNFT – Get Rating) and Opthea (NASDAQ:OPT – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends. Insider and Institutional Ownership 4.5% of Genfit shares are owned by […]
Inhibikase Therapeutics (NYSE:IKT – Get Rating) and Genfit (NASDAQ:GNFT – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk. Risk and Volatility Inhibikase Therapeutics has a beta of 0.94, […]